Louis Fries Selected Research

asparaginyl-proline

1/2021

Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Louis Fries Research Topics

Disease

12	Human Influenza (Influenza) 01/2022 - 01/2006
2	COVID-19 01/2021 - 12/2020
1	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2021
1	Malaria 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Influenza in Birds (Avian Flu) 07/2015
1	Infections 08/2014
1	Anaphylaxis (Anaphylactic Shock) 08/2011
1	Injection Site Reaction 06/2011
1	Pain (Aches) 06/2011
1	Rhinorrhea 01/2006

Drug/Important Bio-Agent (IBA)

12	VaccinesIBA 01/2022 - 01/2006
7	AntigensIBA 01/2021 - 01/2006
5	Influenza Vaccines (Influenza Vaccine)FDA Link 08/2014 - 01/2006
3	Matrix-MIBA 12/2021 - 01/2021
3	AntibodiesIBA 01/2021 - 01/2006
2	NVX-CoV2373 adjuvated lipid nanoparticleIBA 01/2021 - 12/2020
2	AS03 adjuvantIBA 01/2013 - 08/2011
1	asparaginyl-prolineIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Immunoglobulin G (IgG)IBA 12/2020
1	NanovaccinesIBA 01/2018
1	EpitopesIBA 07/2015
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 08/2014
1	Detergents (Detergent)IBA 03/2011
1	Bacterial Outer Membrane ProteinsIBA 03/2011
1	FluLavalIBA 11/2008
1	fluarixIBA 11/2008
1	Membrane Proteins (Integral Membrane Proteins)IBA 03/2006
1	Secretory Immunoglobulin A (SIgA)IBA 01/2006

Therapy/Procedure

1	Intranasal Administration 01/2006